Trial · NCT01156792
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Trough (AM Pre-dose and Pre-rescue Bronchodilator) Forced Expiratory Volume in 1 Second (FEV1) at the End of the 6-week Treatment Period | End of Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Liters (L) | LEAST_SQUARES_MEAN |
| SECONDARY | Daily Trough (Morning Pre-dose and Pre-rescue Bronchodilator) Morning Peak Expiratory Flow (PEF) Averaged Over the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Liters/minute (L/min) | LEAST_SQUARES_MEAN |
| SECONDARY | Daily Evening PEF Averaged Over the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | L/min | LEAST_SQUARES_MEAN |
| SECONDARY | Daily (Average of Morning and Evening) PEF Averaged Over the Last 3 Weeks of the 6 -Week Treatment Period Between GSK2190915 and Montelukast Groups | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | L/min | LEAST_SQUARES_MEAN |
| SECONDARY | Daily Asthma Symptom Score Averaged Over the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Score on a scale | LEAST_SQUARES_MEAN |
| SECONDARY | Daily Rescue Short-acting beta2-agonist (SABA) Use Averaged Over the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Number of inhalations | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Symptom-free Days During the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Percentage of days | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Symptom-free Nights During the Last 3 Weeks of the 6 Week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Percentage of nights | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Rescue-free Days During the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Percentage of days | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Rescue-free Nights During the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Percentage of nights | LEAST_SQUARES_MEAN |
| SECONDARY | Percentage of Nights Without Awakenings Due to Asthma During the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. Only those participants available at the specified time point were analyzed. | Percentage of nights | LEAST_SQUARES_MEAN |
| SECONDARY | Number of Participants Withdrawn Due to Lack of Efficacy During the Last 3 Weeks of the 6-week Treatment Period | Week 4 to Week 6 | ITT Population. | Number of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01156792/outcomes